{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:59:17Z","timestamp":1795089557608,"version":"4.10.2"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The recognition of antigenic peptide-MHC (pMHC) molecules by T-cell receptors (TCR) initiates the T-cell mediated immune response. Structural characterization is key for understanding the specificity of TCR-pMHC interactions and informing the development of therapeutics. Despite the rapid rise of single particle cryoelectron microscopy (cryoEM), x-ray crystallography has remained the preferred method for structure determination of TCR-pMHC complexes. Here, we report cryoEM structures of two distinct full-length \u03b1\/\u03b2 TCR-CD3 complexes bound to their pMHC ligand, the cancer-testis antigen HLA-A2\/MAGEA4 (230\u2013239). We also determined cryoEM structures of pMHCs containing MAGEA4 (230\u2013239) peptide and the closely related MAGEA8 (232\u2013241) peptide in the absence of TCR, which provided a structural explanation for the MAGEA4 preference displayed by the TCRs. These findings provide insights into the TCR recognition of a clinically relevant cancer antigen and demonstrate the utility of cryoEM for high-resolution structural analysis of TCR-pMHC interactions.<\/jats:p>","DOI":"10.1038\/s41467-023-37532-7","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T09:03:21Z","timestamp":1682499801000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Structural analysis of cancer-relevant TCR-CD3 and peptide-MHC complexes by cryoEM"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4135-5356","authenticated-orcid":false,"given":"Kei","family":"Saotome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2934-0127","authenticated-orcid":false,"given":"Drew","family":"Dudgeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiersten","family":"Colotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4078-7242","authenticated-orcid":false,"given":"Ashique","family":"Rafique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George D.","family":"Yancopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4152-4081","authenticated-orcid":false,"given":"Andrew J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1482-0136","authenticated-orcid":false,"given":"Matthew C.","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"key":"37532_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41392-021-00823-w","volume":"6","author":"K Shah","year":"2021","unstructured":"Shah, K., Al-Haidari, A., Sun, J. & Kazi, J. U. T cell receptor (TCR) signaling in health and disease. Signal Transduct. Target Ther. 6, 412 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"37532_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev-immunol-032414-112334","volume":"33","author":"J Rossjohn","year":"2015","unstructured":"Rossjohn, J. et al. T cell antigen receptor recognition of antigen-presenting molecules. Annu Rev. Immunol. 33, 169\u2013200 (2015).","journal-title":"Annu Rev. Immunol."},{"key":"37532_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.immuni.2006.01.006","volume":"24","author":"MS Kuhns","year":"2006","unstructured":"Kuhns, M. S., Davis, M. M. & Garcia, K. C. Deconstructing the form and function of the TCR\/CD3 complex. Immunity 24, 133\u2013139 (2006).","journal-title":"Immunity"},{"key":"37532_CR4","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1126\/science.286.5441.958","volume":"286","author":"TP Arstila","year":"1999","unstructured":"Arstila, T. P. et al. A direct estimate of the human alphabeta T cell receptor diversity. Science 286, 958\u2013961 (1999).","journal-title":"Science"},{"key":"37532_CR5","doi-asserted-by":"publisher","first-page":"794183","DOI":"10.3389\/fonc.2021.794183","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. TCR-T immunotherapy: The challenges and solutions. Front Oncol. 11, 794183 (2021).","journal-title":"Front Oncol."},{"key":"37532_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ctrv.2019.06.001","volume":"77","author":"KL Lowe","year":"2019","unstructured":"Lowe, K. L. et al. Novel TCR-based biologics: mobilising T cells to warm \u2018cold\u2019 tumours. Cancer Treat. Rev. 77, 35\u201343 (2019).","journal-title":"Cancer Treat. Rev."},{"key":"37532_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13045-021-01115-0","volume":"14","author":"AM Tsimberidou","year":"2021","unstructured":"Tsimberidou, A. M. et al. T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors. J. Hematol. Oncol. 14, 102 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"37532_CR8","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nm.3910","volume":"21","author":"AP Rapoport","year":"2015","unstructured":"Rapoport, A. P. et al. NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma. Nat. Med. 21, 914\u2013921 (2015).","journal-title":"Nat. Med."},{"key":"37532_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.molimm.2015.01.024","volume":"67","author":"J Oates","year":"2015","unstructured":"Oates, J., Hassan, N. J. & Jakobsen, B. K. ImmTACs for targeted cancer therapy: Why, what, how, and which. Mol. Immunol. 67, 67\u201374 (2015).","journal-title":"Mol. Immunol."},{"key":"37532_CR10","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s40265-022-01704-4","volume":"82","author":"S Dhillon","year":"2022","unstructured":"Dhillon, S. Tebentafusp: First approval. Drugs 82, 703\u2013710 (2022).","journal-title":"Drugs"},{"key":"37532_CR11","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1056\/NEJMoa2103485","volume":"385","author":"P Nathan","year":"2021","unstructured":"Nathan, P. et al. Overall survival benefit with Tebentafusp in metastatic Uveal Melanoma. N. Engl. J. Med. 385, 1196\u20131206 (2021).","journal-title":"N. Engl. J. Med."},{"key":"37532_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/2051013614525375","volume":"2","author":"JD Comber","year":"2014","unstructured":"Comber, J. D. & Philip, R. MHC class I antigen presentation and implications for developing a new generation of therapeutic vaccines. Ther. Adv. Vaccines. 2, 77\u201389 (2014).","journal-title":"Ther. Adv. Vaccines."},{"key":"37532_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrc.2016.16","volume":"16","author":"SH van der Burg","year":"2016","unstructured":"van der Burg, S. H., Arens, R., Ossendorp, F., van Hall, T. & Melief, C. J. Vaccines for established cancer: overcoming the challenges posed by immune evasion. Nat. Rev. Cancer 16, 219\u2013233 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"37532_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/384134a0","volume":"384","author":"DN Garboczi","year":"1996","unstructured":"Garboczi, D. N. et al. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384, 134\u2013141 (1996).","journal-title":"Nature"},{"key":"37532_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1126\/science.274.5285.209","volume":"274","author":"KC Garcia","year":"1996","unstructured":"Garcia, K. C. et al. An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 274, 209\u2013219 (1996).","journal-title":"Science"},{"key":"37532_CR16","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1093\/bioinformatics\/btz517","volume":"35","author":"R Gowthaman","year":"2019","unstructured":"Gowthaman, R. & Pierce, B. G. TCR3d: The T cell receptor structural repertoire database. Bioinformatics 35, 5323\u20135325 (2019).","journal-title":"Bioinformatics"},{"key":"37532_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cell.2005.07.015","volume":"122","author":"KC Garcia","year":"2005","unstructured":"Garcia, K. C. & Adams, E. J. How the T cell receptor sees antigen\u2013a structural view. Cell 122, 333\u2013336 (2005).","journal-title":"Cell"},{"key":"37532_CR18","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1172\/JCI130562","volume":"130","author":"CJ Holland","year":"2020","unstructured":"Holland, C. J. et al. Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA. J. Clin. Invest. 130, 2673\u20132688 (2020).","journal-title":"J. Clin. Invest."},{"key":"37532_CR19","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1182\/blood-2013-03-490565","volume":"122","author":"GP Linette","year":"2013","unstructured":"Linette, G. P. et al. Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma. Blood 122, 863\u2013871 (2013).","journal-title":"Blood"},{"key":"37532_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep18851","volume":"6","author":"MC Raman","year":"2016","unstructured":"Raman, M. C. et al. Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy. Sci. Rep. 6, 18851 (2016).","journal-title":"Sci. Rep."},{"key":"37532_CR21","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.molimm.2011.03.019","volume":"48","author":"DA Antunes","year":"2011","unstructured":"Antunes, D. A. et al. Structural in silico analysis of cross-genotype-reactivity among naturally occurring HCV NS3-1073-variants in the context of HLA-A*02:01 allele. Mol. Immunol. 48, 1461\u20131467 (2011).","journal-title":"Mol. Immunol."},{"key":"37532_CR22","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.4049\/jimmunol.1302344","volume":"193","author":"K Malecek","year":"2014","unstructured":"Malecek, K. et al. Specific increase in potency via structure-based design of a TCR. J. Immunol. 193, 2587\u20132599 (2014).","journal-title":"J. Immunol."},{"key":"37532_CR23","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/prot.22203","volume":"74","author":"JN Haidar","year":"2009","unstructured":"Haidar, J. N. et al. Structure-based design of a T-cell receptor leads to nearly 100-fold improvement in binding affinity for pepMHC. Proteins 74, 948\u2013960 (2009).","journal-title":"Proteins"},{"key":"37532_CR24","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ymthe.2018.12.010","volume":"27","author":"LM Hellman","year":"2019","unstructured":"Hellman, L. M. et al. Improving T cell receptor on-target specificity via structure-guided design. Mol. Ther. 27, 300\u2013313 (2019).","journal-title":"Mol. Ther."},{"key":"37532_CR25","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/protein\/gzg087","volume":"16","author":"JM Boulter","year":"2003","unstructured":"Boulter, J. M. et al. Stable, soluble T-cell receptor molecules for crystallization and therapeutics. Protein Eng. 16, 707\u2013711 (2003).","journal-title":"Protein Eng."},{"key":"37532_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jim.2009.08.008","volume":"350","author":"GI van Boxel","year":"2009","unstructured":"van Boxel, G. I. et al. Some lessons from the systematic production and structural analysis of soluble (alpha)(beta) T-cell receptors. J. Immunol. Methods 350, 14\u201321 (2009).","journal-title":"J. Immunol. Methods"},{"key":"37532_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jim.2012.06.007","volume":"382","author":"AM Bulek","year":"2012","unstructured":"Bulek, A. M. et al. TCR\/pMHC optimized protein crystallization Screen. J. Immunol. Methods 382, 203\u2013210 (2012).","journal-title":"J. Immunol. Methods"},{"key":"37532_CR28","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41586-019-1537-0","volume":"573","author":"D Dong","year":"2019","unstructured":"Dong, D., Zheng, L., Lin, J., Zhang, B., Zhu, Y. & Li, N. et al. Structural basis of assembly of the human T cell receptor-CD3 complex. Nature 573, 546\u2013552 (2019).","journal-title":"Nature"},{"key":"37532_CR29","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1016\/j.cell.2022.07.010","volume":"185","author":"L Susac","year":"2022","unstructured":"Susac, L. et al. Structure of a fully assembled tumor-specific T cell receptor ligated by pMHC. Cell 185, 3201\u201313.e19 (2022).","journal-title":"Cell"},{"key":"37532_CR30","unstructured":"Moore, M. J., et al. Humanization of T cell-mediated immunity in mice. Sci. Immunol. 6:eabj4026 (2021)."},{"key":"37532_CR31","doi-asserted-by":"publisher","first-page":"e002035","DOI":"10.1136\/jitc-2020-002035","volume":"9","author":"K Davari","year":"2021","unstructured":"Davari, K. et al. Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy. J. Immunother. Cancer 9, e002035 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"37532_CR32","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1016\/j.vaccine.2014.09.002","volume":"32","author":"T Saito","year":"2014","unstructured":"Saito, T. et al. High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine. Vaccine 32, 5901\u20135907 (2014).","journal-title":"Vaccine"},{"key":"37532_CR33","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1002\/(SICI)1521-4141(199910)29:10<3329::AID-IMMU3329>3.0.CO;2-7","volume":"29","author":"MT Duffour","year":"1999","unstructured":"Duffour, M. T. et al. A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytes. Eur. J. Immunol. 29, 3329\u20133337 (1999).","journal-title":"Eur. J. Immunol."},{"key":"37532_CR34","doi-asserted-by":"publisher","first-page":"17576","DOI":"10.1073\/pnas.1420936111","volume":"111","author":"ME Birnbaum","year":"2014","unstructured":"Birnbaum, M. E. et al. Molecular architecture of the alphabeta T cell receptor-CD3 complex. Proc. Natl Acad. Sci. USA 111, 17576\u201317581 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"37532_CR35","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.molcel.2022.02.017","volume":"82","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. Cholesterol inhibits TCR signaling by directly restricting TCR-CD3 core tunnel motility. Mol. Cell. 82, 1278\u20131287.e5 (2022).","journal-title":"Mol. Cell."},{"key":"37532_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nmeth.1293","volume":"6","author":"BR Martin","year":"2009","unstructured":"Martin, B. R. & Cravatt, B. F. Large-scale profiling of protein palmitoylation in mammalian cells. Nat. Methods 6, 135\u2013138 (2009).","journal-title":"Nat. Methods"},{"key":"37532_CR37","doi-asserted-by":"publisher","first-page":"eabe9124","DOI":"10.1126\/science.abe9124","volume":"372","author":"P Zareie","year":"2021","unstructured":"Zareie, P. et al. Canonical T cell receptor docking on peptide-MHC is essential for T cell signaling. Science 372, eabe9124 (2021).","journal-title":"Science"},{"key":"37532_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1146\/annurev.immunol.23.021704.115658","volume":"24","author":"MG Rudolph","year":"2006","unstructured":"Rudolph, M. G., Stanfield, R. L. & Wilson, I. A. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev. Immunol. 24, 419\u2013466 (2006).","journal-title":"Annu Rev. Immunol."},{"key":"37532_CR39","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.4049\/jimmunol.0901276","volume":"183","author":"R Wang","year":"2009","unstructured":"Wang, R., Natarajan, K. & Margulies, D. H. Structural basis of the CD8 alpha beta\/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position. J. Immunol. 183, 2554\u20132564 (2009).","journal-title":"J. Immunol."},{"key":"37532_CR40","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1006\/jmbi.2001.4816","volume":"310","author":"RC Hillig","year":"2001","unstructured":"Hillig, R. C. et al. High-resolution structure of HLA-A*0201 in complex with a tumour-specific antigenic peptide encoded by the MAGE-A4 gene. J. Mol. Biol. 310, 1167\u20131176 (2001).","journal-title":"J. Mol. Biol."},{"key":"37532_CR41","doi-asserted-by":"publisher","first-page":"11486","DOI":"10.1074\/jbc.RA120.014016","volume":"295","author":"CH Coles","year":"2020","unstructured":"Coles, C. H. et al. T cell receptor interactions with human leukocyte antigen govern indirect peptide selectivity for the cancer testis antigen MAGE-A4. J. Biol. Chem. 295, 11486\u201311494 (2020).","journal-title":"J. Biol. Chem."},{"key":"37532_CR42","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.chembiol.2007.07.010","volume":"14","author":"V Mitaksov","year":"2007","unstructured":"Mitaksov, V. et al. Structural engineering of pMHC reagents for T cell vaccines and diagnostics. Chem. Biol. 14, 909\u2013922 (2007).","journal-title":"Chem. Biol."},{"key":"37532_CR43","doi-asserted-by":"publisher","first-page":"10608","DOI":"10.1073\/pnas.1004926107","volume":"107","author":"SR Burrows","year":"2010","unstructured":"Burrows, S. R. et al. Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability. Proc. Natl Acad. Sci. USA 107, 10608\u201310613 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"37532_CR44","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1084\/jem.188.2.277","volume":"188","author":"WW Overwijk","year":"1998","unstructured":"Overwijk, W. W. et al. gp100\/pmel 17 is a murine tumor rejection antigen: induction of \u201cself\u201d-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. J. Exp. Med. 188, 277\u2013286 (1998).","journal-title":"J. Exp. Med."},{"key":"37532_CR45","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1093\/intimm\/11.12.1971","volume":"11","author":"D Valmori","year":"1999","unstructured":"Valmori, D. et al. Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues. Int Immunol. 11, 1971\u20131980 (1999).","journal-title":"Int Immunol."},{"key":"37532_CR46","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.4049\/jimmunol.1000629","volume":"185","author":"DK Cole","year":"2010","unstructured":"Cole, D. K. et al. Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition. J. Immunol. 185, 2600\u20132610 (2010).","journal-title":"J. Immunol."},{"key":"37532_CR47","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/eji.201445114","volume":"45","author":"F Madura","year":"2015","unstructured":"Madura, F. et al. Structural basis for ineffective T-cell responses to MHC anchor residue-improved \u201cheteroclitic\u201d peptides. Eur. J. Immunol. 45, 584\u2013591 (2015).","journal-title":"Eur. J. Immunol."},{"key":"37532_CR48","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.molimm.2021.05.001","volume":"135","author":"JA Alonso","year":"2021","unstructured":"Alonso, J. A., Smith, A. R. & Baker, B. M. Tumor rejection properties of gp100209-specific T cells correlate with T cell receptor binding affinity towards the wild type rather than anchor-modified antigen. Mol. Immunol. 135, 365\u2013372 (2021).","journal-title":"Mol. Immunol."},{"key":"37532_CR49","doi-asserted-by":"publisher","first-page":"e2018125118","DOI":"10.1073\/pnas.2018125118","volume":"118","author":"AR Smith","year":"2021","unstructured":"Smith, A. R. et al. Structurally silent peptide anchor modifications allosterically modulate T cell recognition in a receptor-dependent manner. Proc. Natl Acad. Sci. USA 118, e2018125118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"37532_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.immuni.2006.10.019","volume":"26","author":"S Minguet","year":"2007","unstructured":"Minguet, S., Swamy, M., Alarcon, B., Luescher, I. F. & Schamel, W. W. Full activation of the T cell receptor requires both clustering and conformational changes at CD3. Immunity 26, 43\u201354 (2007).","journal-title":"Immunity"},{"key":"37532_CR51","doi-asserted-by":"publisher","first-page":"31028","DOI":"10.1074\/jbc.M109.052712","volume":"284","author":"ST Kim","year":"2009","unstructured":"Kim, S. T. et al. The alphabeta T cell receptor is an anisotropic mechanosensor. J. Biol. Chem. 284, 31028\u201331037 (2009).","journal-title":"J. Biol. Chem."},{"key":"37532_CR52","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S0021-9258(17)49904-2","volume":"295","author":"RA Mariuzza","year":"2020","unstructured":"Mariuzza, R. A., Agnihotri, P. & Orban, J. The structural basis of T-cell receptor (TCR) activation: An enduring enigma. J. Biol. Chem. 295, 914\u2013925 (2020).","journal-title":"J. Biol. Chem."},{"key":"37532_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/2472555220960401","volume":"26","author":"TM de Oliveira","year":"2021","unstructured":"de Oliveira, T. M., van Beek, L., Shilliday, F., Debreczeni, J. E. & Phillips, C. Cryo-EM: The resolution revolution and drug discovery. SLAS Discov. 26, 17\u201331 (2021).","journal-title":"SLAS Discov."},{"key":"37532_CR54","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.cell.2015.03.049","volume":"161","author":"Y Cheng","year":"2015","unstructured":"Cheng, Y. Single-particle Cryo-EM at crystallographic resolution. Cell 161, 450\u2013457 (2015).","journal-title":"Cell"},{"key":"37532_CR55","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.cell.2020.06.025","volume":"182","author":"CO Barnes","year":"2020","unstructured":"Barnes, C. O. et al. Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies. Cell 182, 828\u201342.e16 (2020).","journal-title":"Cell"},{"key":"37532_CR56","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.abd0827","volume":"369","author":"J Hansen","year":"2020","unstructured":"Hansen, J. et al. Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science 369, 1010\u20131014 (2020).","journal-title":"Science"},{"key":"37532_CR57","doi-asserted-by":"publisher","first-page":"11408","DOI":"10.1073\/pnas.91.24.11408","volume":"91","author":"HC Chang","year":"1994","unstructured":"Chang, H. C. et al. A general method for facilitating heterodimeric pairing between two proteins: application to expression of alpha and beta T-cell receptor extracellular segments. Proc. Natl Acad. Sci. USA 91, 11408\u201311412 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"37532_CR58","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1073\/pnas.89.8.3429","volume":"89","author":"DN Garboczi","year":"1992","unstructured":"Garboczi, D. N., Hung, D. T. & Wiley, D. C. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl Acad. Sci. USA 89, 3429\u20133433 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"37532_CR59","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00251-016-0939-5","volume":"68","author":"SH Krovi","year":"2016","unstructured":"Krovi, S. H. & Gapin, L. Structure and function of the non-classical major histocompatibility complex molecule MR1. Immunogenetics 68, 549\u2013559 (2016).","journal-title":"Immunogenetics"},{"key":"37532_CR60","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.it.2016.08.011","volume":"37","author":"L Van Kaer","year":"2016","unstructured":"Van Kaer, L., Wu, L. & Joyce, S. Mechanisms and consequences of antigen presentation by CD1. Trends Immunol. 37, 738\u2013754 (2016).","journal-title":"Trends Immunol."},{"key":"37532_CR61","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.str.2016.03.004","volume":"24","author":"CL Morales-Perez","year":"2016","unstructured":"Morales-Perez, C. L., Noviello, C. M. & Hibbs, R. E. Manipulation of subunit stoichiometry in heteromeric membrane proteins. Structure 24, 797\u2013805 (2016).","journal-title":"Structure"},{"key":"37532_CR62","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nsmb.1727","volume":"17","author":"A Kirchhofer","year":"2010","unstructured":"Kirchhofer, A. et al. Modulation of protein properties in living cells using nanobodies. Nat. Struct. Mol. Biol. 17, 133\u2013138 (2010).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"37532_CR63","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"37532_CR64","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"SH Scheres","year":"2012","unstructured":"Scheres, S. H. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519\u2013530 (2012).","journal-title":"J. Struct. Biol."},{"key":"37532_CR65","doi-asserted-by":"publisher","first-page":"e42166","DOI":"10.7554\/eLife.42166","volume":"7","author":"J Zivanov","year":"2018","unstructured":"Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 7, e42166 (2018).","journal-title":"Elife"},{"key":"37532_CR66","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"37532_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","volume":"193","author":"K Zhang","year":"2016","unstructured":"Zhang, K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1\u201312 (2016).","journal-title":"J. Struct. Biol."},{"key":"37532_CR68","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1107\/S2059798318004655","volume":"74","author":"TC Terwilliger","year":"2018","unstructured":"Terwilliger, T. C., Sobolev, O. V., Afonine, P. V. & Adams, P. D. Automated map sharpening by maximization of detail and connectivity. Acta Crystallogr D. Struct. Biol. 74, 545\u2013559 (2018).","journal-title":"Acta Crystallogr D. Struct. Biol."},{"key":"37532_CR69","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"37532_CR70","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"37532_CR71","unstructured":"The PyMOL Molecular Graphics System, Version 2.0 Schr\u00f6dinger, LLC."},{"key":"37532_CR72","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2013a visualization system for exploratory research and analysis. J. Comput Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput Chem."},{"key":"37532_CR73","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"37532_CR74","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/pro.2181","volume":"22","author":"BG Pierce","year":"2013","unstructured":"Pierce, B. G. & Weng, Z. A flexible docking approach for prediction of T cell receptor-peptide-MHC complexes. Protein Sci. 22, 35\u201346 (2013).","journal-title":"Protein Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37532-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37532-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37532-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T10:09:06Z","timestamp":1682503746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37532-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["37532"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-37532-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.08.18.504455","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,26]]},"assertion":[{"value":"13 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors own options and\/or stock of Regeneron. G.D.Y., A.J.M., J.C.L., and W.C.O. are officers of Regeneron.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2401"}}